ManagedCareCGM

Continuous Glucose Monitoring

Education for Managed Care, Pharmacy, and Payer Professionals

Quality of Life and Glucose Control After 1 Year of Nationwide Reimbursement of Intermittently Scanned Continuous Glucose Monitoring in Adults Living with Type 1 Diabetes (FUTURE): A Prospective Observational Real-World Cohort Study

Return to Resources *Product Comparison AMCP Formulary Dossiers Clinical Studies Coverage and Benefit Design Featured Resources Health Economics and Outcomes Research (HEOR) Non-CE Education Resources Professional Guidelines Real-World Evidence Review Articles
Tags:

Source: Diabetes Care

Key Takeaway: Nationwide unrestricted reimbursement of isCGM in people with type 1 diabetes treated in specialist diabetes centers results in higher treatment satisfaction, less severe hypoglycemia, and less work absenteeism, while maintaining quality of life and HbA1c.

A1C From Baseline to 12 Months After Initiation of isCGM

Click here to access.

Jointly Provided by

Jointly Provided by

This activity is supported by an independent educational grant from DexCom, Inc.